Cosmos Pharmaceutical Corp banner

Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 6 090 JPY -1.79% Market Closed
Market Cap: ¥487.2B

Cosmos Pharmaceutical Corp
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cosmos Pharmaceutical Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Cosmos Pharmaceutical Corp
TSE:3349
Operating Income
¥40.8B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
8%
Sundrug Co Ltd
TSE:9989
Operating Income
¥46.2B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
4%
Tsuruha Holdings Inc
TSE:3391
Operating Income
¥63B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
8%
Welcia Holdings Co Ltd
TSE:3141
Operating Income
¥40.3B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
11%
S
Sugi Holdings Co Ltd
TSE:7649
Operating Income
¥48.6B
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
8%
MatsukiyoCocokara & Co
TSE:3088
Operating Income
¥84.7B
CAGR 3-Years
11%
CAGR 5-Years
20%
CAGR 10-Years
12%
No Stocks Found

Cosmos Pharmaceutical Corp
Glance View

Market Cap
487.2B JPY
Industry
Retail

In the bustling landscape of Japan's healthcare and beauty industry, Cosmos Pharmaceutical Corp. stands out as a compelling story of strategic ambition and adaptive growth. Established in 1976, the company emerged in Fukuoka, swiftly evolving from a traditional pharmacy into one of the country's most recognized chains of drugstores. Cosmos carved its niche by blending the conveniences of modern retailing with a diverse array of pharmaceutical, health, and personal care products. It's not merely a matter of selling medication; Cosmos transformed the drugstore experience, offering a comprehensive range of products including cosmetics, daily essentials, and food items, which cater to the holistic needs of its customers. This diversification strategy bolsters revenue streams and mitigates risks associated with dependency on any single product category. The company's financial success is further driven by its efficient use of technology and economy of scale. Cosmos Pharmaceutical masterfully implements IT solutions and logistics optimization to manage its expansive network of stores, which number in the thousands across Japan. This not only reduces operational costs but also ensures timely restocking, enhancing consumer satisfaction. The chain's "Everyday Low Pricing" strategy is pivotal to its profitability, drawing in cost-conscious customers and fostering high sales volume. By maintaining streamlined operations and a customer-centric approach, Cosmos cultivates a symbiotic relationship between growth and efficiency, allowing it to thrive in a competitive market and continue its expansion across Japan.

Intrinsic Value
8 666.4 JPY
Undervaluation 30%
Intrinsic Value
Price ¥6 090

See Also

What is Cosmos Pharmaceutical Corp's Operating Income?
Operating Income
40.8B JPY

Based on the financial report for Feb 28, 2026, Cosmos Pharmaceutical Corp's Operating Income amounts to 40.8B JPY.

What is Cosmos Pharmaceutical Corp's Operating Income growth rate?
Operating Income CAGR 10Y
8%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Cosmos Pharmaceutical Corp have been 11% over the past three years , 3% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett